{"id":"W4409097319","doi":"10.1016/s1470-2045(25)00021-x","title":"Patient-reported outcomes from the MIRASOL trial evaluating mirvetuximab soravtansine versus chemotherapy in patients with folate receptor α-positive, platinum-resistant ovarian cancer: a randomised, open-label, phase 3 trial","year":2025,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"ca_institutions":"Institute of Cancer Research","funders":"ImmunoGen; AbbVie","keywords":"Open label; Medicine; Oncology; Folate receptor; Chemotherapy; Internal medicine; Ovarian cancer; Randomized controlled trial; Cancer; Cancer cell","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001853464,0.001586692,0.002486532,0.0002773225,0.0003630143,0.001078305,0.0006657975,0.001770217,0.005423079],"category_scores_gemma":[0.002932041,0.0004695282,0.003152966,0.0003336517,0.0008799633,0.0009485549,0.0005009102,0.003589197,0.0006902477],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009165752,"about_ca_system_score_gemma":0.000679704,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009625783,"about_ca_topic_score_gemma":0.002263446,"domain_scores_codex":[0.9990656,0.0005652423,0.00005320914,0.0001408474,0.00006774516,0.0001073975],"domain_scores_gemma":[0.9983134,0.000588479,0.0004944628,0.0001061929,0.00009398681,0.0004034008],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9842838,0.001548925,0.001255093,0.0005954473,0.002940896,0.00003533921,0.00004497715,0.0003773163,0.001075961,0.0000762648,0.0006681033,0.007097871],"study_design_scores_gemma":[0.9358869,0.0528283,0.006576615,0.0000676347,0.002675289,0.00006187485,0.00004846629,0.0004419604,0.0003346873,0.0002524538,0.0007971411,0.00002877228],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9881725,0.006352689,0.0003139573,0.0009495773,0.0004135903,0.00080237,0.001488762,0.00004538577,0.001461155],"genre_scores_gemma":[0.9910617,0.002147247,0.0006000785,0.0008776999,0.0002971975,0.001005109,0.001980415,0.00001872653,0.00201173],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005423079,"threshold_uncertainty_score":0.01814198,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08608806022690466,"score_gpt":0.4119448152307212,"score_spread":0.3258567550038166,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}